$69.48
+6.08 (+9.59%)
Analyst Consensus
Buy
15
Analysts
High
Coverage
Price Target
Analyst Price Target
-51.7% upside
Low Target
$28.45
Average Target
$33.59
High Target
$56.21
Current Price
$69.48
Current
$69.48
$69.48
Target
$33.59
$33.59
$28.45
$33.59 avg
$56.21
Scenario Analysis
Bear Case
$28.45
-59.1%
Low target
Base Case
$33.59
-51.7%
Avg target
Bull Case
$56.21
+-19.1%
High target
Risk/Reward
0.3x
Unfavorable
Price in Context
52-Week High
$118.84
-41.5% from high
52-Week Low
$29.95
+132.0% from low
50-Day SMA
$97.75
-28.9% vs SMA
200-Day SMA
$64.49
+7.7% vs SMA
RSI (14)
50.6
Neutral
Target vs 52W High
$33.59
-71.7% vs high
Next Earnings Report
Aug 18, 2026
10d
until earnings
EPS Est: $-2.71
Earnings in 10 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 79% | $257.58 | +4.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +172.3% |
| VRTX | Strong Buy | 40 | 83% | $438.34 | -11.6% |
| REGN | Buy | 38 | 71% | $76.80 | -90.2% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -43.4% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.3% |
| BIIB | Buy | 44 | 64% | $91.45 | -55.7% |